There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract may be an effective intervention for the primary and secondary prevention of cognitive impairment and mild to moderate dementia. To confirm the efficacy in patients with mild dementia, Riepe et al. conducted a meta-analysis.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Ginkgo biloba for mild dementia: new meta-analysis
Improvements in several domains relevant to everyday life
- From symptom to diagnosis
Dyspnea – Lung metastases
- Long-term study with dementia patients
Ginkgo biloba extract significantly reduces the risk of progression
- Intestinal microbiome
Complex and fragile system of microorganisms
- Cancer prevention
Poorer prognosis for men who avoid prostate cancer screening
- Diabetes mellitus
Treatment of comorbidities in older people
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- Type 2 diabetes: PAD and diabetic foot syndrome